Plantex

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Plantex - overview

Established

1990

Location

-, -, France

Primary Industry

Chemicals

About

Plantex is a French company specializing in the development and production of high-quality natural plant extracts for diverse industries, including nutraceuticals, food, beverage, animal nutrition, and cosmetics. Founded in 1990 and headquartered in France, Plantex focuses on creating natural botanical extracts, with no noted pivots in business strategy. The company operates independently without any mentioned subsidiaries or parent companies. The founder's history is not specified.


Plantex was acquired by Merieux Equity Partners in December 2020, although financial terms were not disclosed. This acquisition aims to fuel the company's organic growth and support its international expansion efforts. Plantex specializes in the development, production, and marketing of high-quality natural plant extracts for various industries, including nutraceuticals, food and beverage, animal nutrition, and cosmetics. The company offers a diverse range of botanical extracts derived from over 300 plant species, with both conventional and organic (BIO) options.


These extracts are available in various forms, such as liquid bases and dry formats, including gluten-free carriers like maltodextrin. Plantex distributes its products primarily across Europe, catering to manufacturers who require specific formulations for dietary supplements, human and animal nutrition products, and cosmetic items. In 2023, Plantex reported a revenue of USD 30. 22 mn and an EBITDA of USD 5.


33 mn. The company generates revenue through a B2B model, engaging directly with manufacturers that require specialized botanical ingredients. Transactions typically involve bespoke arrangements where clients specify their requirements for plant extracts. Plantex maintains a flexible pricing structure that accommodates various product concentrations and formulations, ensuring alignment with client specifications and industry regulations.


Plantex plans to launch new products aimed at enhancing its range of botanical extracts. Additionally, the company is targeting expansion into new geographic markets, although specific regions and dates have not been disclosed. The acquisition by Merieux Equity Partners will provide the necessary support for these initiatives, facilitating organic growth and international expansion.


Current Investors

Merieux Equity Partners

Primary Industry

Chemicals

Sub Industries

Medicinal Chemicals & Botanicals

Website

www.plantex.fr

Verticals

Manufacturing

Company Stage

Mature - Buyout

Total Amount Raised

Subscriber access only

Plantex - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
BuyoutCompletedPlantex-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.